2013
DOI: 10.1016/j.urolonc.2012.03.015
|View full text |Cite
|
Sign up to set email alerts
|

DNMT1: An emerging target in the treatment of invasive urinary bladder cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(28 citation statements)
references
References 39 publications
0
27
1
Order By: Relevance
“…The expression of estrogen and androgen receptors has also been reported in canine InvUC [19]. In addition, in microarray studies (canine normal bladder, canine InvUC, and human microarray data—GEO database), there were >400 genes differentially expressed between normal and tumor in both dogs and humans [71, 73]. …”
Section: Naturally Occurring Canine Invasive Bladder Cancer and Rementioning
confidence: 99%
See 1 more Smart Citation
“…The expression of estrogen and androgen receptors has also been reported in canine InvUC [19]. In addition, in microarray studies (canine normal bladder, canine InvUC, and human microarray data—GEO database), there were >400 genes differentially expressed between normal and tumor in both dogs and humans [71, 73]. …”
Section: Naturally Occurring Canine Invasive Bladder Cancer and Rementioning
confidence: 99%
“…Aberrant DNA methylation has been identified in multiple genes in human InvUC [107, 108]. DNA methyltransferase 1 (DNMT1), which is a key player in the aberrant methylation process, has been noted to be overexpressed in human and canine InvUC [73, 109]. When considering the design of clinical trials of demethylating agents in humans, key valuable information that could be rapidly obtained from dogs includes efficacy, safety, and treatment scheduling.…”
Section: Examples Of Targeted Therapy Research Utilizing the Caninmentioning
confidence: 99%
“…The inhibition of DNMTs activity has been presented as a possible pathway to reactivate genes silenced by methylation of their promoters in different diseases, including cancer [1,12,18]. The relationship between the hypermethylation of promoter of tumor suppressor genes and cancer development has been clearly demonstrated [3,4,19], suggesting DNMTs as promising drug targets for the discovery of new and more potent/selective anticancer drugs [20].…”
Section: Figure 1 May Go Herementioning
confidence: 99%
“…The selection criteria for NPs was a Total score value greater than 6.0 (-log(Kd)) for both M a n u s c r i p t 12 DNMT structures used, selecting the best 19 NPs as promising DNMTis, as observed in Table 3, which also show affinity values obtained with AutoDock Vina for these compounds. …”
Section: Figure 3 May Go Herementioning
confidence: 99%
See 1 more Smart Citation